BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37627093)

  • 1. Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art.
    Rossi RE; Lavezzi E; Jaafar S; Cristofolini G; Laffi A; Nappo G; Carrara S; Bertuzzi AF; Uccella S; Repici A; Zerbi A; Lania AGA
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmatic and Urinary 5-Hydroxyindolacetic Acid Measurements in Patients With Midgut Neuroendocrine Tumors: A GTE Study.
    de Mestier L; Savagner F; Brixi H; Do Cao C; Dominguez-Tinajero S; Roquin G; Goichot B; Hentic O; Dubreuil O; Hautefeuille V; Walter T; Cadiot G
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1673-e1682. PubMed ID: 33382891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
    Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
    Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid heart disease in patients with midgut neuroendocrine tumours.
    Delhomme C; Walter T; Arangalage D; Suc G; Hentic O; Cachier A; Alkhoder S; François L; Lombard-Bohas C; Iung B; Ruszniewski P; de Mestier L
    J Neuroendocrinol; 2023 Apr; 35(4):e13262. PubMed ID: 37005217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
    Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S
    Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A (CgA) as a biomarker in carcinoid heart disease and NETG1/G2 neuroendocrine neoplasms of the small intestine (SI-NENs) related carcinoid syndrome.
    Konsek-Komorowska SJ; Pęczkowska M; Kolasińska-Ćwikła AD; Konka M; Chrapowicki E; Ćwikła JB
    Med Clin (Barc); 2022 Jul; 159(2):85-89. PubMed ID: 34736622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of thresholds values for platelet serotonin and urinary 5-HIAA concentrations for the biological diagnosis of digestive neuroendocrine tumors].
    Padelli M; Bruno C; Lemarchand J; Vourc'h P; Andres C; Blasco H; Benz-de Bretagne I
    Ann Biol Clin (Paris); 2019 Apr; 77(2):161-168. PubMed ID: 30998196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors.
    Gedde-Dahl M; Thiis-Evensen E; Tjølsen AM; Mordal KS; Vatn M; Bergestuen DS
    Endocr Connect; 2013 Mar; 2(1):50-4. PubMed ID: 23781318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.
    Tirosh A; Nilubol N; Patel D; Kebebew E
    Endocr Pract; 2018 Aug; 24(8):710-717. PubMed ID: 30084688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
    Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
    Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we know about carcinoid heart disease in the present era?
    Pęczkowska M; Konsek-Komorowska SJ; Kolasińska-Ćwikła AD; Konka M; Michałowska I; Ćwikła JB
    Kardiol Pol; 2022; 80(10):990-1001. PubMed ID: 36136036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review.
    Khan MS; Walter T; Buchanan-Hughes A; Worthington E; Keeber L; Feuilly M; Grande E
    World J Gastroenterol; 2020 Aug; 26(30):4537-4556. PubMed ID: 32874063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease.
    Alves C; Mesquita M; Silva C; Soeiro M; Hajjar L; Riechelmann RP
    Ecancermedicalscience; 2018; 12():879. PubMed ID: 30483359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis.
    Forero Molina MA; Garcia E; Gonzalez-Devia D; García-Duperly R; Vera A
    World Allergy Organ J; 2017; 10(1):30. PubMed ID: 28904734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report.
    Kudelka MR; Abou-Alfa GK; O'Reilly EM; Foote MB; Sirohi B; Elias R; Shamseddine A; Paroder V; Moussa AM; Cohen P; Ganesh K
    J Gastrointest Oncol; 2023 Aug; 14(4):1878-1886. PubMed ID: 37720425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease-A Retrospective Study.
    Konsek-Komorowska SJ; Pęczkowska M; Kolasińska-Ćwikła AD; Cichocki A; Konka M; Roszkowska-Purska K; Ćwikła JB
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The ectopic ACTH syndrome].
    Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
    Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study.
    Uema D; Alves C; Mesquita M; Nuñez JE; Siepmann T; Angel M; Rego JFM; Weschenfelder R; Rocha Filho DR; Costa FP; Barros M; O'Connor JM; Illigens BM; Riechelmann RP
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30909590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
    Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
    Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis.
    Joish VN; Shah S; Tierce JC; Patel D; McKee C; Lapuerta P; Zacks J
    Future Oncol; 2019 Apr; 15(12):1397-1406. PubMed ID: 30734573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.